Improve Outcomes and Lower Costs

Improve outcomes- Wellinks Images

Let’s Reinvent COPD
Care Together

For a tailored financial impact analysis for your plan, contact us today at:
Thank you! Your request has been sent!
Oops! Something went wrong while submitting the form.
Chronic Obstructive Pulmonary Disease
COPD: A $49 Billion Healthcare Cost

Chronic Obstructive Pulmonary Disease (COPD) represents the 3rd most expensive cause for avoidable hospitalizations, right after heart failure and diabetes. Emergency department visits, hospitalizations, and readmissions drive 75% of the $49 B price tag.

In our national analysis of claims data, we found that for the average member diagnosed with COPD, 43% of claims ($13,000 of $30,000) were COPD-related.. Combine this with the 14% prevalence of COPD in US adults over 65 - the numbers are staggering.  

Proactive, longitudinal care improves self-management and has been proven to reduce 55% of COPD-related hospitalizations and readmissions. Historically, people living with COPD have had limited access to these services.

You can change this with Wellinks.

COPD By the Numbers

14%

Diagnosed prevalence of COPD in a Medicare population

$13K

Per member per year (PMPY)
COPD-related direct cost

75%

Costs driven by ED visits, hospitalizations, and readmissions — many of these are avoidable with improved self-management
Baseline $12K PMPY COPD-related Direct Cost Breakdown
Inpatient and ED
75%
OP
12%
Other*
13%
* Other includes nursing, home health and ambulance.
This is where Wellinks comes in.

How We Improve Outcomes

Personalized COPD self-management support has been shown to reduce key COPD cost drivers.

~50% Reduced COPD Costs

ROI percentage - Wellinks Images
What you'll save
With Wellinks, our partners can reduce COPD-related medical expense by up to 50%, which translates to a total savings of
$6.9M
per 1000 Wellinks members
This translates to
2.5-3X ROI
Check out our enrollment toolkit to see how we increase uptake rate.
Wellinks logo white stacked - Wellinks Images

Let’s Reinvent COPD Together

For a tailored financial impact analysis for your plan, contact us today at:

Thank you! Your request has been sent!
Oops! Something went wrong while submitting the form.

Wellinks: Personalized COPD Self-Management Support

Wellinks is a virtual-first provider of personalized, comprehensive, and integrated COPD management.
Green icon of three users, one with a check mark on it's head - Wellinks Images
Identification
We work with our clients to identify the COPD population that would most benefit from Wellinks.
Green Icon of a square diagram  - Wellinks Images
Wellinks Risk Stratification
Our proprietary risk stratification allows us to personalize our program and connect members to a solution that works for them.
Green icon of three users with cogs as heads  - Wellinks Images
Personalized COPD Management
Each member receives a personalized
program of health coaching, pulmonary health, connected devices, and an easy-to-use app to support their COPD journey and connect members to a solution that works for them.

Our Additional Benefits

For your plan
In the US, indirect costs from COPD added up to $20.4 B in spending each year. Taking these into consideration, Wellinks can help save your plan more than what is included in this report.
Excess costs icon - Wellinks Images
Reduction of excessive
costs associated with
comorbidities
Improved scores icon - Wellinks Images
Improvement of HEDIS
and CAHPS scores (e.g., access to spirometry testing, behavioral health service, etc.)
Vertical spacer  - Wellinks Images
For your people
Lifestyle and emotional costs emerge as patients’ daily functioning declines. It exacts an enormous toll, emotionally and physically on patients, their family, and caregivers. Wellinks can help here too.
Quality of life icon - Wellinks Images
Improvement of our
members productivity
and quality of life
Family icon green - Wellinks Images
Reduction of emotional and physical strain on family and caregivers

Our ROI Calculation Methodology

1
Baseline spend was determined through an analysis of Medicare fee-for-service claims from CMS’s 5% sample in 2019, trended forward to 2023.
2
Wellinks projected impact on COPD-related costs were based on an extensive literature analysis of similar clinical models in COPD care.
3
Wellinks uptake rate is based on ongoing experience and similar disease management solutions.
4
Interested in seeing the impact Wellinks can have on your business? Reach out for a tailored impact model!
ROI- Wellinks Images